Demosthenes Panagiotakos, Alexandra Tragaki
Tag Archives: cardiovascular disease
Parental health status and children’s eating behaviors: An epidemiological study in 1728 Greek 10-12 years old students
Maria Bogri, Aikaterini Kanellopoulou, Venetia Notara, George Antonogeorgos, Andrea-Paola Rojas-Gil, Ekaterina Kornilaki, Maria-Eleni Kordoni, Anna Velentz, Magdalini Mesimeri, Rena I. Kosti, Areti Lagiou, Demosthenes B. Panagiotakos
COVID-19 outbreak: The heart in the center?
Christina Chrysohoou, Evangelos Oikonomou, Aggelos Papanikolaou, Panagiotis Xydis, Costas Tsioufis
Cardiorenal effects of newer antidiabetic agents
Athanasia K. Papazafiropoulou, Elias Georgopoulos, Stavros Antonopoulos
Competing risks’ analysis in cardiovascular disease epidemiology; – Τhe case of ATTICA study (2002-2012)
Thomas Tsiampalis, Demosthenes Panagiotakos
PCSK9 inhibitors: The breakthrough lipid-lowering treatment at real-life setting – A 2-year regional lipid clinic experience
Georgia Anastasiou, George Liamis, Haralampos Milionis, Moses Elisaf, Eliza Christopoulou, Theodora Dimitriou, Evangelos N. Liberopoulos
Arterial hypertension in renal transplantation: Clinical implications, pathogenesis and current management strategies
Duni Anila, Paraskevi Pavlakou, Vasileios Koutlas, Irini Tzalavra, Charalambos Pappas, Michalis Mitsis, Evangelia Dounousi
Can tea consumption reduce the risk of CVD? A discussion paper of a recently published cohort study
Sofia –Panagiota Giannakopoulou, Demosthenes Panagiotakos
Recurrent events among Acute Coronary Syndrome patients: gender-specific analysis from Aegean-Islands study
Matina Kouvari, Demosthenes B Panagiotakos, NG Patsourakos, A Kotidis, S Chantanis, K Kalantzi, M Tsoumani, A Kartalis, N Smyrnioudis, S Fousas, AD Tselepis
The role of angiopoietin-like 3 in the metabolism of lipoproteins: therapeutic perspectives
Christos Rizos, Matilda Florentin, Moses Elisaf